相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
Yoshiko Atsuta et al.
BLOOD (2009)
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Renato Bassan et al.
BLOOD (2009)
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison
Jan J. Cornelissen et al.
BLOOD (2009)
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993
Adele K. Fielding et al.
BLOOD (2009)
Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival
M. J. Burke et al.
BONE MARROW TRANSPLANTATION (2009)
The Extent of Minimal Residual Disease Reduction After the First 4-Week Imatinib Therapy Determines Outcome of Allogeneic Stem Cell Transplantation in Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Seok Lee et al.
CANCER (2009)
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group
Peter Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
Francoise Huguet et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Allogeneic Hematopoietic Stem Cell Transplantation in Adult Acute Lymphocytic Leukemia: Impact of Donor Source on Survival
Priya Kumar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Allogeneic hematopoietic cell transplantation for adult Philadelphia-positive acute lymphoblastic leukemia in the era of tyrosine kinase inhibitors
Yasser R. Abou Mourad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock et al.
BLOOD (2008)
Allogeneic hematopoietic cell transplantation for adults with ALL
R. A. Larson
BONE MARROW TRANSPLANTATION (2008)
The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients
B. Sirohi et al.
BONE MARROW TRANSPLANTATION (2008)
Allogeneic transplantation for ALL in adults
A. Stein et al.
BONE MARROW TRANSPLANTATION (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty et al.
HAEMATOLOGICA (2008)
Acute lymphoblastic leukemia in adolescents and young adults in Finland
Anu Usvasalo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the programa espanol de tratamiento en hematologia pediatric-based protocol ALL-96
Josep-Maria Ribera et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research
M. R. Bishop et al.
BONE MARROW TRANSPLANTATION (2008)
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H. Goldstone et al.
BLOOD (2008)
Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review
V. Bachanova et al.
BONE MARROW TRANSPLANTATION (2008)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy:: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol
Marco Vignetti et al.
BLOOD (2007)
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
Elly Barry et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials
Ramya Ramanujachar et al.
PEDIATRIC BLOOD & CANCER (2007)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Adele K. Fielding et al.
BLOOD (2007)
Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia - A metaanalysis
Masamitsu Yanada et al.
CANCER (2006)
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann et al.
BLOOD (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: An evidence-based review
T Hahn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Treatment with monoclonal antibodies in acute lymphoblastic leukemia:: current knowledge and future prospects
N Gökbuget et al.
ANNALS OF HEMATOLOGY (2004)
The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission:: a donor vs no donor comparison
V Gupta et al.
BONE MARROW TRANSPLANTATION (2004)
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT:: a GOELAMS trial
M Hunault et al.
BLOOD (2004)
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
DA Thomas et al.
BLOOD (2004)
Outcome of treatment in adults with acute lymphoblastic leukemia:: Analysis of the LALA-94 trial
X Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia -: results of the prospective multicenter LALA-94 trial
H Dombret et al.
BLOOD (2002)
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
J Takeuchi et al.
LEUKEMIA (2002)
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation -: A follow-up report of the French protocol LALA 87
A Thiebaut et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
分享论文
